- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips captures volumes with new iU22 technology
Philips’ new xMatrix brings real-time volumetric scanning to radiology as part of the company’s latest version of the iU22 ultrasound scanner. First built into Philips’ echocardiography systems five years ago, a souped-up version built into the company’s flagship iU22 on the RSNA exhibit floor quickly captures volumes in the abdomen that can be interrogated in 2D planes any time after the patient has left the exam room. Two planes can be viewed simultaneously using Live xPlane. Images drawn from the volume can then be sent to any PACS.
Philips’ new xMatrix brings real-time volumetric scanning to radiology as part of the company’s latest version of the iU22 ultrasound scanner. First built into Philips’ echocardiography systems five years ago, a souped-up version built into the company’s flagship iU22 on the RSNA exhibit floor quickly captures volumes in the abdomen that can be interrogated in 2D planes any time after the patient has left the exam room. Two planes can be viewed simultaneously using Live xPlane. Images drawn from the volume can then be sent to any PACS.
Integrated with PureWave technology, xMatrix works with the new X6-1 transducer. The combination allows operators of different skill levels to achieve the same quality imaging, according to Philips. The key is the xMatrix transducer with elements arranged along the X and Y planes. The 9000 electronically controlled elements replace the mechanical 3D arrays of the past, capturing volumes of data that can be easily interrogated.
Today this volumetric technology is available only in an abdominal probe, but in time it will become available on Philips’ solid-state transducers for endocavitary, vascular, and small parts applications. While there is no specific timeline for the migration of this technology, Philips executives say the company is definitely headed in this direction.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
